Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th Street, Starr-434 Pavilion, New York, NY 10021, USA.
Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th Street, Starr-434 Pavilion, New York, NY 10021, USA.
Interv Cardiol Clin. 2020 Apr;9(2):197-206. doi: 10.1016/j.iccl.2019.12.001. Epub 2020 Jan 29.
Endovascular intervention devices for femoral-popliteal arterial disease have evolved in the last decade to more effectively treat patients with symptoms of claudication, improve tissue healing, and prevent amputation in patients with critical limb ischemia. Drug-eluting stents and drug-coated balloon therapies have demonstrated significant improvements in short- and mid-term patency and decreases in future target vessel interventions over uncoated balloon angioplasty. Adjunctive lesion preparation options including atherectomy devices are available to treat more complex and calcified lesions, but comparative data are still required.
在过去的十年中,用于股腘动脉疾病的血管内介入治疗装置不断发展,以更有效地治疗跛行症状患者,促进组织愈合,并预防临界肢体缺血患者的截肢。药物洗脱支架和药物涂层球囊治疗在短期和中期通畅率方面显示出显著改善,并降低了未来靶血管介入治疗的风险,优于未涂层球囊血管成形术。还可采用旋切装置等辅助病变准备选择来治疗更复杂和钙化病变,但仍需要比较数据。